PSORIGEL

Serial Number 73115333
Registration 1074417
900

Registration Progress

Application Filed
Feb 10, 1977
Under Examination
Approved for Publication
Published for Opposition
Registered
Oct 4, 1977

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: PSORIGEL
Previous Owner: HEALTHPOINT, LTD.

Trademark Image

PSORIGEL

Basic Information

Serial Number
73115333
Registration Number
1074417
Filing Date
February 10, 1977
Registration Date
October 4, 1977
Renewal Date
October 4, 1997
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
900
Status Date
Jul 11, 2008

Rights Holder

HEALTHPOINT, LTD.

13
Address
2400 HANDLEY EDERVILLE ROAD
FORT WORTH, TX 76118

Ownership History

ALCON LABORATORIES, INC.

Original Registrant
03
FORT WORTH, TX

HEALTHPOINT, LTD.

New Owner After Registration #14
13
FORT WORTH, TX

Legal Representation

Attorney
William D. Wiese

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

12 events
Date Code Type Description Documents
May 27, 2015 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Jul 11, 2008 CAEX O CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 Loading...
Nov 21, 2007 CFIT O CASE FILE IN TICRS Loading...
Jul 10, 2007 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 10, 2007 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 16, 2006 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 16, 2006 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 26, 2005 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 13, 2004 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 11, 1998 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Oct 1, 1997 9.AF I REGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8 Loading...
Jun 6, 1983 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...